There is always a bull market somewhere.

Despite shifting headlines and constantly evolving market narratives, certain stocks and sectors continue to benefit from prevailing economic regimes. In the

Shares of Tredegar Corporation TG have underperformed the broader market following the release of its fourth-quarter results. The stock has declined 3.4% since the earnings announcement for the

Reinsurance Group of America RGA is a leading global provider of traditional life and health reinsurance, as well as financial solutions, with operations across the United States, Latin America

Keros Therapeutics KROS posted a dramatic revenue jump in 2025, but the mix matters as much as the magnitude. The shares also trade at a steep discount to book value, creating the classic biotech

Keros Therapeutics KROS enters 2026 with a clearer catalyst stack and a tighter operational focus. The near-term setup is led by rinvatercept, with study starts and regulatory interactions now

Keros Therapeutics, Inc. KROS is pushing its lead asset, rinvatercept, into neuromuscular disease with Duchenne muscular dystrophy at the front of the line. The company is positioning the program

For investors seeking momentum, Horizon Landmark ETF BENJ is probably on the radar now. The fund just hit a 52-week high and is up 4.4% from its 52-week low price of $50.07 per share.

But are there

In a stunning revelation at its latest annual GTC conference, NVIDIA NVDA CEO Jensen Huang announced that the company now expects to secure up to $1 trillion in chip orders for its next-generation

Genuine Parts Company GPC, based in Atlanta, is a distributor of automotive and industrial replacement parts and materials. The company operates a vast network of more than 10,800 locations